Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Eriochrome Blue Black B. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.60 |
| ▸ | MPL | P40238 | 10/20 | 0.78 |
| ▸ | CTRC | Q99895 | 2/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.62 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.62 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.56 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | MMP14 | P50281 | 1/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | PTPRA | P18433 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eriochrome Blue Black B SCHEMBL18281602 | 1.00 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| Eriochrome Blue Black B SCHEMBL591901 | 1.00 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL29756484 | 0.90 | MPL (0.63) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL29429572 | 0.89 | MPL (0.61) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL4596966 | 0.88 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL4596970 | 0.88 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL2220292 | 0.88 | CYP1A2 (0.84) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL31707292 | 0.88 | CYP1A2 (0.84) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL29402956 | 0.88 | CYP1A2 (0.84) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL338777 | 0.88 | CYP1A2 (0.84) | MPLCTRCCYP1A2CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731636-A2 | METHODS FOR THE SYNTHESIS AND LINEARIZATION OF PEPTIDOMIMETIC MACROCYCLES | Dana-Farber Cancer Institute, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4711042-A1 | TARGET OBJECT SEPARATION APPARATUS WITH IMPROVED QUALITY CONTROL, AND MANUFACTURING METHOD THEREOF | CURIOSIS INC. (KR) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024263911-A9 | METHODS FOR THE SYNTHESIS AND LINEARIZATION OF PEPTIDOMIMETIC MACROCYCLES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2025018998-A1 | ASSAY STACK WITH SEPARATION MEMBRANE CONTAINING SOLUBLE POLYMER COATING TO CONTROL FLOW RATE | GOOGLE LLC (US) | 2025-01-23 | — | — | WO | disclosed |
| US-20250003964-A1 | Assay Device and Method for Measuring Sodium Concentration in Blood Using Ion-Cryptand Complex Depletion | GOOGLE LLC | 2025-01-02 | — | — | US | disclosed |
| WO-2024263911-A2 | METHODS FOR THE SYNTHESIS AND LINEARIZATION OF PEPTIDOMIMETIC MACROCYCLES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240375105-A1 | DEVICE FOR SEPARATING TARGET OBJECT WITH IMPROVED QUALITY CONTROL AND MANUFACTURING METHOD THEREOF | CURIOSIS INC. (KR) | 2024-11-14 | — | — | US | disclosed |
| WO-2024232662-A1 | TARGET OBJECT SEPARATION APPARATUS WITH IMPROVED QUALITY CONTROL, AND MANUFACTURING METHOD THEREOF | 주식회사 큐리오시스 | 2024-11-14 | — | — | WO | disclosed |
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240165259-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-05-23 | — | — | US | disclosed |
| EP-4320073-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | Dana-Farber Cancer Institute, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| EP-4313013-A2 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | Dana-Farber Cancer Institute, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023107109-A1 | ASSAY DEVICE AND METHOD FOR MEASURING SODIUM CONCENTRATION IN BLOOD USING ION-CRYPTAND COMPLEX DEPLETION | GOOGLE LLC (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2022216616-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022204344-A2 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | ENO1, HIF1A, HIF1AN | THRB 1913/4885MPL 2649/4885CTRC 4252/4885 |
| US-20240165259-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | CILK1, SYMPK, DCK | THRB 2290/4885MPL 585/4885CTRC 1423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.